There is great hope in finding cancer medications that have been brought about by the introduction of mRNA vaccinations that are used for keeping off Covid-19. The medical experts use vaccines, advanced surgical methods, and personalized treatments to see whether they can come up with precision medicine for cancer patients. Tempus CEO Eric Lefkofsky attended an interview with the front-liner oncologist Siddhartha Mukherjee to discuss how the introduction of precision medicine provided hope to cancer treatment soon.
According to Eric Lefkofsky, it will be a relief when thousands of individuals stop losing their lives to cancer in 3, 4, or 5 decades to come. When that comes, fewer people will have cancer, and it will be treated as a rare disease. Eric believes that the Covid-19 pandemic is one of the best examples (Wikiwand).
Tempus works on different issues simultaneously by using large amounts of data and pipes to bring it together and produce it in the healthcare system. Currently, they are working on precise Covid-19 testing. According to Eric Lefkofsky, that is what the professionals plan to do with cancer treatment. The other vaccine is used on cancer patients to prevent the spread of cancer cells and helps in the prevention of the spread of cancer.
The vaccine is therapeutic, and Eric believes that mRNA will help save lives because Tempus can easily manufacture them. In addition, they can provide a strong immunity against cancer. However, he noted that the production of the vaccines would depend on the experts’ ability to get more facts about cancer. The professionals, such as Eric Lefkofsky look forward to finding mechanisms that they can use to prevent cancer and its spread during the early stages. They hope that they can accomplish that without the need for blood tests and scans, among other methods.